National Health Investors (NYSE:NHI – Get Rating) had its price target dropped by investment analysts at Truist Financial from $64.00 to $61.00 in a report issued on Monday, The Fly reports. Truist Financial’s price objective suggests a potential upside of 2.97% from the company’s current price.
Other research analysts have also recently issued research reports about the stock. Credit Suisse Group assumed coverage on shares of National Health Investors in a research report on Wednesday, June 22nd. They set an “underperform” rating on the stock. BMO Capital Markets cut shares of National Health Investors from an “outperform” rating to a “market perform” rating and set a $62.00 price target on the stock. in a research report on Tuesday, June 21st. Finally, Capital One Financial began coverage on shares of National Health Investors in a research report on Friday, June 3rd. They issued an “overweight” rating and a $64.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors presently has an average rating of “Hold” and a consensus target price of $59.50.
National Health Investors Trading Down 2.4 %
Shares of NHI opened at $59.24 on Monday. National Health Investors has a 52-week low of $50.22 and a 52-week high of $67.16. The company has a quick ratio of 12.92, a current ratio of 12.92 and a debt-to-equity ratio of 0.79. The firm’s fifty day moving average is $64.20 and its two-hundred day moving average is $59.95. The stock has a market cap of $2.65 billion, a PE ratio of 40.58 and a beta of 0.86.
Insider Activity at National Health Investors
In other National Health Investors news, Director Robert G. Adams purchased 1,500 shares of the stock in a transaction that occurred on Monday, August 15th. The stock was purchased at an average cost of $65.93 per share, with a total value of $98,895.00. Following the completion of the acquisition, the director now directly owns 85,411 shares of the company’s stock, valued at approximately $5,631,147.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 7.26% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On National Health Investors
Large investors have recently modified their holdings of the company. Teacher Retirement System of Texas lifted its holdings in shares of National Health Investors by 7.3% during the first quarter. Teacher Retirement System of Texas now owns 8,955 shares of the real estate investment trust’s stock worth $528,000 after purchasing an additional 607 shares during the period. GSA Capital Partners LLP purchased a new position in National Health Investors in the fourth quarter worth $573,000. Aigen Investment Management LP purchased a new position in National Health Investors in the first quarter worth $289,000. TCI Wealth Advisors Inc. raised its position in National Health Investors by 566.0% in the first quarter. TCI Wealth Advisors Inc. now owns 706 shares of the real estate investment trust’s stock worth $42,000 after acquiring an additional 600 shares in the last quarter. Finally, Teamwork Financial Advisors LLC purchased a new position in National Health Investors in the first quarter worth $225,000. 65.25% of the stock is owned by institutional investors and hedge funds.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.